Physician profile
Peter A Ameck
NPI 1679622989
$720.74
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.31 · 2023: $434 · 2024: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $154.03 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $109.30 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $99.29 | 2023-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $89.96 | 2023-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $54.43 | 2023-2024 | Trelegy Ellipta |
| Vanda Pharmaceuticals INC. | $52.56 | 2023 | Hetlioz |
| Exact Sciences Corporation | $51.04 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $36.75 | 2023 | |
| Corcept Therapeutics | $24.47 | 2024 | Korlym |
| Amgen INC. | $22.30 | 2023 | Repatha, Otezla |
| Lundbeck LLC | $15.30 | 2024 | Rexulti |
| Dexcom, INC. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ameck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.